Plant composition and application thereof in preparation of breast enlarging product

Abstract

The invention relates to the technical field of biological medicine, and particularly discloses a plant composition and application thereof in preparation of breast enlarging products. The plant composition is prepared from the following raw material components: sunflower seed oil, a dioscorea villosa root extract, a radix puerariae extract, a papaya fruit extract, an acetyl hexapeptide-7 aqueous solution and an African chandelia fruit extract. Researches show that the composition composed of the six raw materials can achieve a synergistic effect and has an excellent breast enlarging effect; therefore, further application value in preparation of a product with a breast enlarging effect by using the compound as an active component is important.

Description

Technical Field

[0001] The present invention relates to the technical field of biomedicine, and in particular to a plant composition and application thereof in preparing breast enhancement products. Background Art

[0002] As women's pursuit of beauty continues to grow, the market demand for breast enhancement products continues to expand. While the product range is rich and the services are diverse, the variety of breast enhancement products on the market varies greatly, and some products contain hormonal ingredients, posing a potential threat to human health. Complications after cosmetic implant surgery include capsular contracture leading to breast deformation, firmness, discomfort, or pain, implant displacement, infection, or implant rupture and leakage, all of which harm human health and cause problems in all aspects of consumers' lives. Therefore, the development of a safe and effective breast enhancement botanical composition and breast enhancement cream is of great significance.

[0003] Breast development is influenced by a combination of factors. Internal factors are primarily genetic, with size, shape, and structure largely influenced by the genes inherited from the mother or grandmother. Hormone levels are primarily influenced by estrogen and progesterone. Estrogen is a key hormone that promotes breast tissue growth and development, and progesterone works synergistically with estrogen to promote the development of mammary alveoli. Other hormones, including growth hormone (GH), insulin, thyrotropin-releasing hormone (TRH), and adrenocorticoid hormones (adrenocorticoids) and their receptors, all play a role in breast development and secretory function. External factors, primarily nutritional status, are crucial for breast and breast tissue development during adolescence. Lifestyle, specific chest exercises and training, and chest fitness routines can promote chest muscle development and firmness. Poor standing and sitting posture can also affect the breasts and rib cage, leading to breast hypoplasia. Furthermore, the choice of underwear is one of the main factors influencing breast development.

[0004] Therefore, a breast enhancement cosmetic is provided that adds a combination of natural plant herbal ingredients, simulates the effect of estrogen, uses scientific methods to add plant extracts, and promotes breast blood circulation through massage of breast enhancement cream, provides external nutrition and moisturizing for the breasts, stimulates the development of breast tissue, and enables the breasts to grow naturally, which has important application value. Summary of the Invention

[0005] In order to overcome at least one of the technical problems existing in the prior art, the present invention provides a plant composition and its application in preparing breast enhancement products.

[0006] The technical solutions of the present invention are as follows: The present invention first provides a plant composition, which comprises the following raw material components: sunflower seed oil, Dioscorea zingiberensis root extract, Pueraria root extract, papaya fruit extract, acetyl hexapeptide-7 aqueous solution and African chandelier tree fruit extract.

[0007] Based on the breast enhancement mechanism, the present invention screened out a composition consisting of six raw materials, including sunflower seed oil, Dioscorea zingiberensis root extract, Pueraria root extract, papaya fruit extract, African chandelier tree fruit extract, and acetyl hexapeptide-7 aqueous solution, after extensive experiments. Studies have shown that the composition consisting of the six raw materials of the present invention can synergize with each other and has an excellent breast enhancement effect; the breast enhancement effect of the composition is significantly higher than that of other known raw material combinations.

[0008] Sunflower oil is sunflower (HELIANTHUS ANNUUS) seed oil, reed grass is a solution of Dioscorea zingiberensis (DIOSCOREAVILLOSA) root extract, kudzu root is kudzu root (PUERARIA LOBATA) extract, papaya is papaya (CHAENOMELES SINENSIS) fruit extract, sausage fruit is a solution of African chandelier tree (KIGELIA AFRICANA) fruit extract, and acetyl hexapeptide-7 aqueous solution is an aqueous solution of acetyl hexapeptide-7 with a content of 500 ppm.

[0009] Sunflower (HELIANTHUS ANNUUS) seed oil contains a large amount of essential unsaturated fatty acids, such as linoleic acid, which promotes cell regeneration and growth, protects skin health, and reduces cholesterol accumulation in the blood. Furthermore, linoleic acid, an essential fatty acid, significantly aids in human development and physiological regulation, and can contribute to healthy breast enhancement. Sunflower seeds are rich in trace elements such as iron, zinc, potassium, and magnesium, which can help prevent breast diseases. They are also a good source of vitamins B1, B3, and E, essential for breast enhancement, and have a positive effect on breast enhancement and beauty. Sunflower seed oil is a high-energy food that can accelerate breast enhancement.

[0010] Dioscorea villosa root extract, whose main component is diosgenin, has a molecular structure very similar to that of natural progesterone in the human body and has estrogen-like effects. After entering the human body, it can serve as the raw material of natural progesterone, activating the human endocrine glands, promoting the secretion of hormones needed by the human body, regulating endocrine balance, and thereby promoting breast development and fullness, and improving the firmness and elasticity of the breast skin.

[0011] Pueraria lobata extract is obtained from the dried roots of the leguminous plant Pueraria lobata. Modern research shows that Pueraria lobata is rich in nutrients such as isoflavones, polyphenols, starch, protein, and various trace elements, and has high nutritional and medicinal value. The structure of Pueraria lobata extract is similar to estrogen, and the structure of phytoestrogens is relatively stable. The structural characteristics similar to estrogen enable Pueraria lobata flavonoids to bind to estrogen receptors (ER), thereby exhibiting estrogen activity, promoting the secondary development of the ovaries, making the breasts plump and firm, and reconstructing breast tissue. It can quickly activate dormant breast tissue and promote the redevelopment of breast tissue, and can also promote the health of the uterus and ovaries. It also has the function of preventing cardiovascular disease. Pueraria lobata flavonoids are natural phytoestrogens. Natural phytoestrogens are different from chemical hormones and will not have side effects on the human body.

[0012] Papaya (CHAENOMELES SINENSIS) fruit extract, rich in vitamins and enzymes, helps promote breast tissue metabolism and cell regeneration. Its strong antioxidant capacity helps the body repair tissue, eliminate toxic substances, and enhance immunity, helping the body resist viruses including influenza A. Papaya's beneficial ingredients, when absorbed through the skin, stimulate the secretion of the pituitary gland, enzymes, and hormones, regulating breast microcirculation and ultimately promoting breast enlargement.

[0013] Kigelia Africana fruit extract, also known as sausage fruit extract, is native to tropical Africa. It contains a large amount of flavonoids and phytosterols. Kigelia fruit flavonoids are natural and safe phytoestrogens that bind to estrogen receptors in the body, exerting a weak estrogenic effect. Kigelia fruit flavonoids can also promote endocrine function, effectively stimulate the regeneration of breast cells and tissues, and accelerate their metabolism. They also effectively regulate and distribute fat throughout the body, encouraging fat to migrate and accumulate around the breasts, improving skin firmness and elasticity, thereby achieving breast enhancement.

[0014] The above active ingredients work together to have a synergistic effect, balance hormone secretion, regulate estrogen, and can be used for breast care to make the breasts develop again; they can regulate the body's endocrine function, dredge the meridians, activate breast cells, repair and tighten the breast skin, enhance the vitality of the breast skin, replenish skin nutrition, have excellent antioxidant and moisturizing activity, lift the skin around the chest, tighten and elasticize it, and restore the breasts to a firm and plump appearance.

[0015] Preferably, the plant composition comprises the following raw material components in parts by weight: 0-10 parts of sunflower seed oil, 0-2 parts of Dioscorea zingiberensis root extract, 0-2 parts of Pueraria root extract, 0-2 parts of papaya fruit extract, 0-5 parts of acetyl hexapeptide-7 aqueous solution, and 0-3 parts of African chandelier tree fruit extract.

[0016] Preferably, the plant composition comprises the following raw material components in parts by weight: 5-10 parts of sunflower seed oil, 0.5-2 parts of Dioscorea zingiberensis root extract, 0.5-2 parts of Pueraria root extract, 0.5-2 parts of papaya fruit extract, 1-5 parts of acetyl hexapeptide-7 aqueous solution, and 1-3 parts of African chandelier tree fruit extract.

[0017] The present invention also provides an application of the plant composition in preparing breast enhancement products.

[0018] Preferably, the breast enhancement product is a breast enhancement cream.

[0019] Preferably, the breast enlargement cream comprises the above-mentioned plant composition.

[0020] Preferably, the breast enlargement cream further comprises an adjuvant.

[0021] Preferably, the auxiliary agent comprises one or a combination of more than one of a moisturizer, an emulsifier, an emulsifying stabilizer, an auxiliary skin conditioner, a moisturizer, a thickener, a raw material additive with preservative effect, a penetration enhancer, an antioxidant, and a pH neutralizing regulator.

[0022] Preferably, the breast enhancement cream further comprises aromatic essential oil.

[0023] Preferably, the breast enhancement cream comprises the following components in weight percentage: 0-25% of the above-mentioned breast enhancement plant composition, 5-30% of a moisturizer, 2-6% of an emulsifier, 0.5-2% of an emulsifying stabilizer, 2-10% of an auxiliary skin conditioner, 1-10% of an emollient, 0.5-2% of a thickener, 1-5% of a raw material additive with an antiseptic effect, 0.5-2% of a penetration enhancer, 0.2-1% of an antioxidant, 0-0.5% of a pH neutralizing regulator, 0.2-1% of an essential oil, and the balance being water.

[0024] Preferably, the moisturizing agent is selected from one or a mixture of glycerin, butylene glycol, panthenol, and sodium hyaluronate.

[0025] Preferably, the emulsifier is selected from liquid crystal emulsifiers; the emulsification stabilizer is selected from cetearyl alcohol; Preferably, the auxiliary skin conditioning agent is selected from one or a combination of allantoin, dipotassium glycyrrhizate, menthol, borneol, vanillyl butyl ether, and arnica.

[0026] Preferably, the thickener is selected from one or a combination of AVC (ammonium acryloyldimethyltaurate / VP copolymer), U20 carbomer (acrylic acids / C10-30 alkyl acrylate crosspolymer).

[0027] Preferably, the emollient is selected from one or a combination of dimethicone, caprylic / capric triglyceride, dimethiconol, and ethylhexyl palmitate.

[0028] Preferably, the penetration enhancer is selected from one or a combination of dimethyl isosorbide, laurocapram, diethoxydiglycol, and tetrahydropiperine.

[0029] Preferably, the raw material additive with antiseptic properties is selected from 1,2-hexanediol and / or p-hydroxyacetophenone.

[0030] Preferably, the antioxidant is selected from tocopherol acetate.

[0031] Preferably, the pH neutralizing regulator is selected from arginine, tromethamine, triethanolamine, sodium hydroxide, and potassium hydroxide; and the aromatic essential oil is selected from one or a combination of jasmine (JASMINUM SAMBAC) flower oil, rosemary (ROSMARINUS OFFICINALIS) leaf oil, jasmine (JASMINUM SAMBAC) flower oil, and Petersburg pine (LEPTOSPERMUM PETERSONII) oil.

[0032] Beneficial effects: The present invention provides a new plant composition. Studies have shown that the composition composed of the six raw materials of the present invention can synergize with each other and has an excellent breast enhancement effect; therefore, further using it as an active ingredient in the preparation of products with breast enhancement effects has important application value.

[0033] In addition, studies have shown that the plant composition of the present invention and the breast enhancement cream product prepared therefrom have a soothing effect on the human body, do not cause allergic irritation to humans, and can be used safely. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 This is a graph showing the experimental results of the breast enhancement cream of the present invention on the expression rate of PGC-1ɑ.

[0035] Figure 2 This is the experimental result of breast enhancement cream increasing the fat content in differentiated cells.

[0036] Figure 3 Breast volume increase experimental results for breast enhancement cream testing. DETAILED DESCRIPTION

[0037] The present invention will be further described in detail below with reference to specific examples, but the examples do not limit the present invention in any form.

[0038] Example 1 Preparation of plant composition 5 parts of sunflower seed oil, 0.5 parts of Dioscorea zingiberensis root extract, 0.5 parts of Pueraria root extract, 0.5 parts of papaya fruit extract, 1 part of 500 ppm acetyl hexapeptide-7 aqueous solution, and 1 part of African chandelier tree fruit extract were mixed uniformly to obtain a plant composition.

[0039] Example 2 Preparation of plant composition 8 parts of sunflower seed oil, 1 part of Dioscorea zingiberensis root extract, 1 part of Pueraria root extract, 1 part of papaya fruit extract, 3 parts of 500 ppm acetyl hexapeptide-7 aqueous solution, and 2 parts of African chandelier tree fruit extract were mixed uniformly to obtain a plant composition.

[0040] Example 3 Preparation of plant composition 10 parts of sunflower seed oil, 2 parts of Dioscorea zingiberensis root extract, 2 parts of Pueraria root extract, 2 parts of papaya fruit extract, 5 parts of 500 ppm acetyl hexapeptide-7 aqueous solution, and 5 parts of African chandelier tree fruit extract were mixed uniformly to obtain a plant composition.

[0041] Example 4 Preparation of breast enhancement cream According to the mass percentage composition of the raw materials in Table 1, breast enhancement creams No. 1 to No. 4 were prepared.

[0042] Table 1 Raw material composition of breast enhancement cream No. 1 to No. 4 (mass percentage, total amount 100%)

[0043] The preparation method of the above-mentioned breast enhancement cream No. 1 to No. 4 comprises the following steps: We chose the thickener acrylic acid (ester) / C10-30 alkyl acrylate crosspolymer that needs to be neutralized and combined it with ammonium acryloyldimethyltaurate / VP copolymer for thickening. According to the above raw materials, they are divided into five phases according to their own characteristics: phase A high-temperature water phase, phase B high-temperature oil phase, phase C anti-corrosion treatment phase, phase D neutralization adjustment phase, and phase E low-temperature phase.

[0044] Step 1: Clean and disinfect the production equipment and tools; weigh each group of raw materials according to the formula and record them. Add phase A to the main emulsification pot and phase B to the oil pot; Step 2: Stirring and heating: Turn on the main emulsification pot and oil pot at the same time and stir and heat to 80-85℃, stirring and dispersing until the ingredients are evenly mixed. Keep the emulsification pot warm for 10-15 minutes, add phase B to the emulsification pot and homogenize for 3-5 minutes, stir evenly, and cool down; Step 3, cooling process: cool to 70℃, add pre-heated dissolved phase C (heating does not exceed 70℃), homogenize for 1-3 minutes, stir evenly, cool to 50-55℃, add phase D into the emulsifier, stir evenly, and continue cooling; Step 4: Cooling and discharging: After the temperature drops to 40-45°C, add phase E, stir evenly, and filter the material; Step 5, let the material stand still: mark the material after it is discharged and make production records. Step 6: Material testing: sampling and testing of physical, chemical and microbiological indicators; Step 7, filling and packaging: After passing the inspection, the inner packaging materials are sterilized and then the filling and packaging process is carried out to transform them into trial test products; Step 8. Repeat steps 1 to 7 according to the content of each component in Cases 1-4 to prepare four groups of test products in Cases 1-4, which are labeled as Breast Enlargement Cream No. 1, Breast Enlargement Cream No. 2, Breast Enlargement Cream No. 3, and Breast Enlargement Cream No. 4 respectively.

[0045] Experimental Example 1 Sensory, physical and chemical, and hygiene index tests Table 2 Sensory indicators of breast enhancement cream

[0046] Table 3 Physical and chemical indicators of breast enhancement cream

[0047] Table 4 Hygiene indicators of breast enhancement cream

[0048] Based on the test results of the experimental cases in Tables 2, 3 and 4, the sensory, physical and chemical, and hygienic indicators of the prepared breast enhancement cream product all meet the requirements and can be made into a stable product.

[0049] Experimental Example 2 Soothing efficacy test According to the test method of JYT-SOP-JC-04 "Detailed Rules for Verification and Testing of Soothing Efficacy of Cosmetics", the soothing efficacy of four groups of breast enhancement cream products was tested by laboratory methods.

[0050] 1. Experimental Principle and Basis Hyaluronidase is a hydrolase that degrades hyaluronic acid, a major component of the extracellular matrix of connective tissue. It is associated with most IgE-mediated type I and T-cell-mediated type IV allergic reactions. Therefore, in vitro hyaluronidase inhibition tests can, to a certain extent, reflect the skin soothing, anti-allergic, and anti-inflammatory effects of a product. Hyaluronic acid is a higher polysaccharide composed of D-glucuronic acid and N-acetylglucosamine, and it undergoes a colorimetric reaction using the Elson-Morgan reaction. This reaction can be used to determine the hyaluronidase inhibition rate of a sample.

[0051] This test determines the hyaluronidase inhibition rate of the sample according to the test method of JYT-SOP-JC-04 "Detailed Rules for Verification and Testing of Soothing Efficacy of Cosmetics" and determines whether the sample has soothing effect by comparing it with the negative control.

[0052] 2. Experimental steps 2.1 Accurately weigh the sample and perform extraction pretreatment on the sample; 2.2 The pretreated samples were processed according to the modified Elson-Morgan reaction, and negative controls were set up; 2.3 Follow the test kit to measure the OD value; 2.4 Calculate the hyaluronidase inhibition rate.

[0053] 3. Correlation between experimental indicators and soothing effects ;

[0054] T – The amount of hyaluronidase measured after the test C – Amount of hyaluronidase added before the test The results of this test are characterized by the inhibition rate of the sample on hyaluronidase, which is compared with the negative control with soothing effect. If the test sample group has an inhibition rate compared with the negative control, and the test sample group has a significant difference compared with the negative control, it means that the test sample group has a soothing effect.

[0055] The significant differences were statistically analyzed using SPSS software, and when the significance factor P < 0.05, it was considered to be a significant difference.

[0056] IV. Experimental results and statistical analysis Two parallel experiments were performed on the test samples and negative controls, and the results were analyzed for significant differences. The statistical analysis results are as follows: Table 5 Inhibition rate significance analysis table

[0057] 5. Experimental Conclusion According to the test method of QTTZ-XZ-35 "Detailed Rules for Verification and Testing of Soothing Efficacy of Cosmetics", the soothing efficacy of four groups of breast enhancement cream cases was tested by laboratory methods; the test results showed that the hyaluronidase inhibition rate of test sample breast enhancement cream No. 1 was 47.52%, the hyaluronidase inhibition rate of test sample breast enhancement cream No. 2 was 47.17%, the hyaluronidase inhibition rate of test sample breast enhancement cream No. 3 was 47.39%, and the hyaluronidase inhibition rate of test sample breast enhancement cream No. 4 was 47.39% (analyzed by SPSS software, using a two-tailed test, the significance factor P < 0.05), which was significantly lower than the negative control, indicating that the breast enhancement cream products prepared in the cases have a soothing effect on the human body, will not cause allergic irritation to humans, and can be used safely.

[0058] Experimental Example 3 In vitro fat cell test Adipose tissue is specialized connective tissue located beneath the skin. It can undergo rapid and extensive changes in size because it has no anatomical constraints on growth and accumulates lipids from the diet, thereby increasing both cellular and local volume. Therefore, the amount of subcutaneous fat and its distribution across the body play a key role in appearance and depend on diet, age, hormones, gender, and exercise habits. In women, fat is primarily located in the hips, thighs, and buttocks, unlike in men and menopausal women, who primarily store fat in the abdomen and waist.

[0059] White adipose tissue (WAT), the prevalent type of tissue in adults, serves as the primary storage site for the daily intake of lipids (triglycerides and cholesterol esters), which are burned whenever the body's cells need energy. While adipocytes are the predominant cells in WAT, the tissue also contains preadipocytes (adipocyte precursor cells, 15-50%), macrophages, fibroblasts, leukocytes, and numerous collagen fibers that provide structural support. Adipocytes contain large lipid droplets (80% of the cell contents), which constrain the nucleus and cytoplasm to the cell periphery. One of the most relevant characteristics of mature adipocytes is their ability to accumulate triglycerides, whereas preadipocytes cannot.

[0060] WAT volume can vary depending on the number and size of adipocytes, a parameter that increases with lipid accumulation. The number of mature adipocytes, capable of storing lipids, increases due to a differentiation process that converts preadipocytes into mature adipocytes. This maturation is a complex process known as adipogenesis, in which both peroxisome proliferator-activated receptor-γ (PPARγ) and peroxisome proliferator-activated receptor-γ coactivator 1ɑ (PGC-1ɑ) are essential.

[0061] PPAR-γ belongs to a family of nuclear receptor proteins that function as transcription factors and regulate gene expression during cell differentiation. This receptor is primarily expressed in adipose tissue and forms a heterodimer with the retinoid X receptor, which binds to specific regions of the DNA of target genes and regulates their expression. PPAR-γ is absolutely necessary, but not sufficient, for preadipocyte differentiation.

[0062] PGC-1ɑ is a transcriptional coactivator that interacts with multiple transcription factors and nuclear receptors, increasing the likelihood that certain genes involved in adipogenesis will be transcribed. "A significant induction of PGC-1ɑ expression was observed during ex vivo differentiation of human subcutaneous preadipocytes in water-attenuated tissue (WAT), reaching levels comparable to those in mature adipocytes." In WAT, PGC-1ɑ coactivates PPAR-γ, which subsequently positively regulates the expression of genes necessary to convert preadipocytes into mature adipocytes capable of lipid accumulation. Therefore, stimulating or reducing PGC-1ɑ expression can increase or decrease adipocyte maturation, thereby increasing local volume.

[0063] Expression of key elements of adipogenesis The efficacy of Breast Enhancement Creams No. 1-4 was investigated individually by quantitative real-time PCR to determine the effect on PGC-1a expression. Human subcutaneous preadipocytes were incubated at 37°C in preadipocyte growth medium (PGM-2) for 24 hours, which served as a basal control (untreated, undifferentiated cells). Differentiation was induced by switching this medium to preadipocyte differentiation medium (PDM-2), which served as a control for untreated, differentiated cells. During the differentiation process, Breast Enhancement Creams No. 1-4 were added, and all samples were incubated at 37°C for 10 days.

[0064] The cells are then lysed, RNA is extracted, and reverse transcribed. The resulting cDNA is analyzed by RT-PCR, which uses an endogenously expressed control (eukaryotic 18S ribosomal subunit RNA) to correlate the cDNA with the native mRNA levels present in the sample. Fluorescence is analyzed to quantify native PGC-1ɑ mRNA levels.

[0065] Effects on lipid accumulation Human subcutaneous preadipocytes were incubated in PGM-2 at 37°C for 24 hours, followed by a switch to PDM-2 to induce adipogenesis. The cells were then incubated for 10 days in the presence of different treatments (Breast Enhancement Creams 1-4). PDM-2 served as a negative control, and PGM-2 as a basal control. After 10 days of incubation, intracellular glyceride accumulation was measured using the AdipoRed assay reagent. The supernatant was removed, the wells were washed, and 5 μL of AdipoRed reagent was added. After incubation at room temperature for 15 minutes, fluorescence was measured using an automated multiplate fluorescence reader set to excitation at 485 nm and detection at 535 nm.

[0066] Results and Conclusions Analysis like Figure 1 and Figure 2 As shown in the data, Breast Enlargement Cream No. 1 increased the expression rate of PGC-1ɑ by 0.3%, Breast Enlargement Cream No. 2 increased the expression rate of PGC-1ɑ by 24.6%, Breast Enlargement Cream No. 3 increased the expression rate of PGC-1ɑ by 62.1%, and Breast Enlargement Cream No. 4 increased the expression rate of PGC-1ɑ by 62.5%.

[0067] Breast Enlargement Cream No. 1 increased the fat content in differentiated cells by 0.2%, Breast Enlargement Cream No. 2 increased the fat content in differentiated cells by 21.3%, Breast Enlargement Cream No. 3 increased the fat content in differentiated cells by 28.9%, and Breast Enlargement Cream No. 4 increased the fat content in differentiated cells by 32.4%.

[0068] From the above data, we can see that the breast enhancement cream No. 1 in the control group has no significant change in the breast enhancement effect, while breast enhancement cream No. 2, breast enhancement cream No. 3, and breast enhancement cream No. 4 effectively improve skin elasticity, plump breasts, and exert breast enhancement effects.

[0069] Experimental Example 4 Breast volume increase efficacy test A group of 60 women (aged 25-40) with bra sizes between 80 and 90 were enrolled. Fifteen women were assigned to the placebo group (Breast Cream No. 1) and 15 women were assigned to the treatment groups (Breast Cream No. 2, Breast Cream No. 3, and Breast Cream No. 4). Breast volume was measured at baseline and on days 14, 28, and 56 using the Fast Optical In Vivo Topology (FOITS) technique, which reconstructs the breast surface and volume based on optical interferometry. The relative volumes of the regions and different 3D images were obtained, and the difference in mm3 from baseline and the change in breast volume were calculated.

[0070] Breast enlargement cream massage is very effective for breast enlargement. Each of the following movements should be repeated 8-10 times, and each time should last for 5 minutes.

[0071] You can also apply breast enhancement cream directly on your breasts, and then gently spread it evenly on your breasts with your hands. Be careful to pour a small amount of breast enhancement cream on your hands, avoiding sensitive areas such as nipples and areolas. If you feel that it is not very moisturizing during the subsequent massage and there is a feeling of astringency, you can add a small amount of breast enhancement cream at any time.

[0072] The massage technique is divided into 4 steps: (1) Open your thumb and forearms, put your four fingers together, and push from both sides of your chest toward the center. Push 30 times on each side. This will prevent your chest from expanding outward.

[0073] (2) Keeping your hands in the same position, start with your right breast. Use your right hand to push it toward the center from the outside. Then, use your left hand to push upward from the bottom of your right breast until it reaches your collarbone. In other words, use your two hands to push your right breast alternately. Repeat 30 times, then switch to your left breast. This exercise is very helpful for firming breasts.

[0074] (3) Shape your hands into a bra shape, with your five fingers slightly apart, enough to hold your breasts. Then bend down slightly, cup your breasts with both hands, and lift from the bottom toward the nipple. Repeat 20 times. Note that the bottom of the breast does not refer to the lower part of the breast.

[0075] (4) Use both hands to make circular massage around the breasts until all the essential oil is absorbed.

[0076] Follow the above procedure twice daily when testing the product.

[0077] like Figure 3 As shown, the product started to take effect in the second week. For the placebo group, the average breast volume increased by 20 mm3 on the 14th day, 100 mm3 on the 28th day, and 80 mm3 on the 56th day for the breast enhancement cream No. 1 through application and manipulation; the average breast volume increased by 550 mm3 on the 14th day for the breast enhancement cream No. 2 in the drug-treated group, 900 mm3 on the 28th day, and 930 mm3 on the 56th day; the average breast volume increased by 800 mm3 on the 14th day for the breast enhancement cream No. 3 in the drug-treated group, 1200 mm3 on the 28th day, and 1300 mm3 on the 56th day; the average breast volume increased by 850 mm3 on the 14th day for the breast enhancement cream No. 4 in the drug-treated group, 1230 mm3 on the 28th day, and 1380 mm3 on the 56th day. The test data show that the breast enlargement cream prepared from the breast enlargement plant composition of the present invention can effectively improve skin elasticity, plump up breasts, and exert breast enlargement effects.

[0078] In summary, the present invention provides a safe and effective breast enhancement plant composition and breast enhancement cream. Persistent use can effectively improve problems such as flat breasts and sagging breasts, effectively improve skin elasticity, make the breasts fuller and firmer, and enhance the breast size, thereby achieving breast enhancement effects, and has significant market application prospects.

[0079] The above description is merely a preferred embodiment of the present invention and does not constitute any form of limitation to the present invention. Although the present invention has been disclosed as a preferred embodiment as above, it is not intended to limit the present invention. Any person skilled in the art can make some changes or modifications to equivalent embodiments using the technical contents disclosed above without departing from the scope of the technical solution of the present invention. However, any indirect modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention are still within the scope of the technical solution of the present invention.

Claims

1. A plant composition, characterized in that Contains the following raw materials: sunflower seed oil, Dioscorea zingiberensis root extract, Pueraria root extract, papaya fruit extract, acetyl hexapeptide-7 aqueous solution and African chandelier tree fruit extract.

2. The plant composition according to claim 1, characterized in that The invention comprises the following raw material components in parts by weight: 0-10 parts of sunflower seed oil, 0-2 parts of Dioscorea zingiberensis root extract, 0-2 parts of Pueraria root extract, 0-2 parts of papaya fruit extract, 0-5 parts of acetyl hexapeptide-7 aqueous solution, and 0-3 parts of African chandelier tree fruit extract.

3. The plant composition according to claim 2, characterized in that The invention comprises the following raw material components in parts by weight: 5-10 parts of sunflower seed oil, 0.5-2 parts of Dioscorea zingiberensis root extract, 0.5-2 parts of Pueraria root extract, 0.5-2 parts of papaya fruit extract, 1-5 parts of acetyl hexapeptide-7 aqueous solution, and 1-3 parts of African chandelier tree fruit extract.

4. Use of the plant composition according to any one of claims 1 to 3 in the preparation of breast enhancement products.

5. The use according to claim 4, characterized in that The breast enlargement product is a breast enlargement cream.

6. The use according to claim 5, characterized in that The breast enlargement cream comprises the plant composition according to any one of claims 1 to 3.

7. The use according to claim 6, characterized in that The breast enlargement cream further comprises an auxiliary agent.

8. The use according to claim 6, characterized in that The auxiliary agent comprises one or more of a moisturizer, an emulsifier, an emulsification stabilizer, an auxiliary skin conditioner, a moisturizer, a thickener, a raw material additive with antiseptic properties, a penetration enhancer, an antioxidant, and a pH neutralizing regulator.

9. The use according to claim 6, characterized in that The breast enlargement cream also contains aromatic essential oil.

10. The use according to claim 5, characterized in that The breast enlargement cream comprises the following components in percentage by weight: The breast enhancement plant composition according to any one of claims 1 to 3 comprises 0-25% of a moisturizer 5-30%, an emulsifier 2-6%, an emulsification stabilizer 0.5-2%, an auxiliary skin conditioning agent 2-10%, an emollient 1-10%, a thickener 0.5-2%, a raw material additive with antiseptic properties 1-5%, a penetration enhancer 0.5-2%, an antioxidant 0.2-1%, a pH neutralizing regulator 0-0.5%, an essential oil 0.2-1%, and the balance water.

Images